Conference
A phase II study of lapatinib in recurrent or metastatic EGFR and/or ErbB2 expressing adenoid cystic (ACC) and non-ACC malignant tumors of the salivary glands (MSGT).
Authors
Agulnik M; Cohen EE; Cohen RB; Chen EX; Hotte SJ; Winquist E; Laurie S; Hayes DN; Dancey JE; Siu LL
Volume
24
Pagination
pp. 296S-296S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 20, 2006
Name of conference
42nd Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
Atlanta, GA
Conference start date
June 2, 2006
Conference end date
June 6, 2006
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
18
ISSN
0732-183X